This early study from an internationally-renowned team at Imperial College London provides 'first in human' evidence that a combined therapy using the hormones glucagon and glucagon-like peptide 1 (GLP-1) may form the basis for a new treatment for obesity and diabetes in the future.
What does GLP stand for?
GLP stands for Glucagon-Like Peptide
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of GLP
We have 116 other meanings of GLP in our Acronym Attic
- Gas Licuado de Petroleo (Spanish: Liquefied Petroleum Gas)
- Gás Liquefeito de Petróleo (Portugese: Liquefied Petroleum Gas)
- Generalized Linear Phase
- Generalized Logic Program (computer programming)
- Geographic Location Profile
- Get Low Playas (rap group)
- Gibson Les Paul (guitar)
- Global Land Project (joint research project of the International Geosphere-Biosphere Programme and the Human Dimension Programme on Global Environmental Change)
- Global Learning Portal (Washington, DC)
- Global License Program (Symantec)
Samples in periodicals archive:
The company spent nearly 10 years developing a molecule that would act like a naturally occurring hormone called GLP-1, short for glucagon-like peptide 1, a naturally occurring compound that works on different organs to lower blood sugar levels.
Glucagon-like peptide (GLP)-2 reduces chemotherapy associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor.
Multisite regulation of insulin secretion by cAMP-increasing agonist: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
Called glucagon-like peptide 1 (GLP1), the beneficial compound stimulates the release of insulin from the pancreas and maintains insulin-making beta cells housed in that organ.
The gut hormones peptide YY (PYY) and glucagon-like peptide 1 (GLP-1), which are both released into circulation after we eat, are known to play some role in that process.
A new class of experimental drugs that mimic the actions of the hormone glucagon-like peptide 1 showed benefits against type 2, or adult-onset, diabetes.
Previous studies on that gut hormones, such as peptide YY (PYY) and glucagon-like peptide (GLP-1), has shown that their release after a meal acts on the brain and induces satiety and meal termination.